<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03990025</url>
  </required_header>
  <id_info>
    <org_study_id>2018/2895</org_study_id>
    <nct_id>NCT03990025</nct_id>
  </id_info>
  <brief_title>Linked Color Imaging vs White Light Imaging for Detection of Gastric Cancer Precursors</brief_title>
  <official_title>A Prospective Randomized Study of Linked Color Imaging and Conventional White Light Imaging in Gastroscopy for the Detection of Gastric Cancer Precursors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changi General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Singapore General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Changi General Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to examine the use of Linked Color Imaging in detection of gastric cancer
      precursors, as well as oesophageal and duodenal lesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gastric cancer is the fifth most common cause of death worldwide. Early detection and removal
      of gastric cancer precursors and early gastric cancer is crucial for good outcomes. However,
      these lesions are subtle and often missed by conventional white light imaging (WLI)
      endoscopy. Image enhanced endoscopy techniques have been developed to enhance the detection
      and characterization of gastrointestinal lesions. Narrow band imaging (NBI) is one such
      technique. Though widely used, its drawbacks include a limited far view as a result of the
      optical filter causing a dark endoscopic view. Linked color imaging (LCI) is a more recent
      image enhanced endoscopy technique that acquires images by using both narrow-band wavelength
      light and white light in an appropriate balance, enhancing slight color differences in the
      red region of mucosa. It has been proven to improve detection of H pylori gastritis and
      colorectal neoplasms. Thus far, there has been no study to determine whether the use of LCI
      will increase the detection rate of gastric cancer precursors and early gastric cancer
      compared to WLI. This study aims to determine whether LCI can increase the detection rate of
      gastric cancer precursors and early gastric cancer when compared to white light endoscopy,
      with the null hypothesis being no difference in detection rates. This study will also examine
      the use of LCI with magnification to predict histology findings for focal lesions seen on
      endoscopy, as well as the use of LCI in identifying esophageal lesions (such as Barett's
      esophagus) and duodenal lesions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 27, 2019</start_date>
  <completion_date type="Anticipated">October 17, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 17, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in detection rate of gastric lesions between Linked Color Imaging and White Light Imaging</measure>
    <time_frame>Immediately following the procedure</time_frame>
    <description>Includes Intestinal Metaplasia, Gastric Adenoma, Low Grade Dysplasia, High Grade Dysplasia, Early Gastric Cancer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in detection rate of oesophageal lesions between Linked Color Imaging and White Light Imaging</measure>
    <time_frame>Immediately following the procedure</time_frame>
    <description>Includes Barrett's Oesophagus, Low Grade Dysplasia, High Grade Dysplasia, Early Oesophageal Cancer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in detection rate of duodenal lesions between Linked Color Imaging and White Light Imaging</measure>
    <time_frame>Immediately following the procedure</time_frame>
    <description>Includes Duodenal adenoma, Duodenal adenocarcinoma</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and Specificity of detection of gastric lesions</measure>
    <time_frame>Upon histological confirmation - within 2 weeks of the procedure</time_frame>
    <description>Includes Intestinal Metaplasia, Gastric Adenoma, Low Grade Dysplasia, High Grade Dysplasia, Early Gastric Cancer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and Specificity of detection of oesophageal lesions</measure>
    <time_frame>Upon histological confirmation - within 2 weeks of the procedure</time_frame>
    <description>Includes Barrett's Oesophagus, Low Grade Dysplasia, High Grade Dysplasia, Early Oesophageal Cancer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and Specificity of detection of duodenal lesions</measure>
    <time_frame>Upon histological confirmation - within 2 weeks of the procedure</time_frame>
    <description>Includes Duodenal adenoma, Duodenal adenocarcinoma</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Early Gastric Cancer</condition>
  <condition>Barrett Esophagus</condition>
  <arm_group>
    <arm_group_label>Linked Color Imaging - White Light Imaging</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participant undergoes gastroscopy via Linked Color Imaging first, then followed by White Light Imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>White Light Imaging - Linked Color Imaging</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participant undergoes gastroscopy via White Light Imaging first, then followed by Linked Color Imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Linked Color Imaging</intervention_name>
    <description>Linked Color Imaging (LCI) is a form of image enhanced endoscopy that uses a laser endoscopic system that acquires images by simultaneously using narrow-band wavelength light and white light in an appropriate balance. This enhances slight color differences in the red region of the mucosa.</description>
    <arm_group_label>Linked Color Imaging - White Light Imaging</arm_group_label>
    <arm_group_label>White Light Imaging - Linked Color Imaging</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>White Light Imaging</intervention_name>
    <description>White Light Imaging (WLI) uses conventional white light that encompasses all bandwidths of light to illuminate areas of interest to obtain endoscopic images.</description>
    <arm_group_label>Linked Color Imaging - White Light Imaging</arm_group_label>
    <arm_group_label>White Light Imaging - Linked Color Imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 50 years and above

          -  Patients undergoing gastroscopy for symptom evaluation

          -  Patients undergoing gastroscopy for surveillance of known intestinal metaplasia

        Exclusion Criteria:

          -  Emergent gastroscopy performed for suspected acute GI bleeding

          -  Patients with previous surgical/endoscopic resection in stomach

          -  Patients with deranged coagulation and platelet function (INR&gt;1.5, Plt&lt;50)

          -  Patients with severe comorbid illness (ASA 3 and above)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tiing Leong Ang, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changi General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tiing Leong Ang, MBBS</last_name>
    <phone>67888833</phone>
    <email>ang.tiing.leong@singhealth.com.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nway Nway Aye</last_name>
    <phone>67888833</phone>
    <email>nway_nway_aye@cgh.com.sg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>169608</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vikneswaran s/o Namasivayam, MBBS</last_name>
      <phone>62223322</phone>
      <email>vikneswaran.namasivayam@singhealth.com.sg</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Changi General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>529889</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiing Leong Ang, MBBS</last_name>
      <phone>67888833</phone>
      <email>ang.tiing.leong@singhealth.com.sg</email>
    </contact>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <results_reference>
    <citation>Dohi O, Yagi N, Onozawa Y, Kimura-Tsuchiya R, Majima A, Kitaichi T, Horii Y, Suzuki K, Tomie A, Okayama T, Yoshida N, Kamada K, Katada K, Uchiyama K, Ishikawa T, Takagi T, Handa O, Konishi H, Naito Y, Itoh Y. Linked color imaging improves endoscopic diagnosis of active Helicobacter pylori infection. Endosc Int Open. 2016 Jul;4(7):E800-5. doi: 10.1055/s-0042-109049.</citation>
    <PMID>27556101</PMID>
  </results_reference>
  <results_reference>
    <citation>Paggi S, Mogavero G, Amato A, Rondonotti E, Andrealli A, Imperiali G, Lenoci N, Mandelli G, Terreni N, Conforti FS, Conte D, Spinzi G, Radaelli F. Linked color imaging reduces the miss rate of neoplastic lesions in the right colon: a randomized tandem colonoscopy study. Endoscopy. 2018 Apr;50(4):396-402. doi: 10.1055/a-0580-7405. Epub 2018 Mar 14.</citation>
    <PMID>29539651</PMID>
  </results_reference>
  <results_reference>
    <citation>Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol. 2013;26(1):11-22. Review.</citation>
    <PMID>24714327</PMID>
  </results_reference>
  <results_reference>
    <citation>Sun X, Dong T, Bi Y, Min M, Shen W, Xu Y, Liu Y. Linked color imaging application for improving the endoscopic diagnosis accuracy: a pilot study. Sci Rep. 2016 Sep 19;6:33473. doi: 10.1038/srep33473.</citation>
    <PMID>27641243</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 27, 2019</study_first_submitted>
  <study_first_submitted_qc>June 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2019</study_first_posted>
  <last_update_submitted>January 22, 2020</last_update_submitted>
  <last_update_submitted_qc>January 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Barrett Esophagus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

